MG
CVS icon

Marex Group’s CVS Health CVS Stock Holding History

Marex Group’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-36,559
Closed -$1.64M – 720
2024
Q4 		$1.64M Buy
36,559
+18,591
+103% +$1.04M 0.03% 179
2024
Q3 		$1.13M Sell
17,968
-9,317
-34% -$544K 0.03% 200
2024
Q2 		$1.61M Sell
27,285
-51,699
-65% -$3.23M 0.04% 180
2024
Q1 		$6.3M Sell
78,984
-11,388
-13% -$870K 0.2% 72
2023
Q4 		$7.14M Buy
90,372
+59,357
+191% +$4.22M 0.28% 70
2023
Q3 		$2.17M Buy
31,015
+17,434
+128% +$1.24M 0.31% 48
2023
Q2 		$939K Buy
+13,581
New +$966K 0.17% 94

Other funds holding CVS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Marex Group's CVS Position: Q1 2025 in Review

Marex Group sold out of CVS Health (CVS) in Q1 2025, closing a stake of 36,559 shares — an estimated $1.64M sold.

Marex Group first reported a position in CVS in Q2 2023 and held it in 7 quarters. The position peaked at $7.14M in Q4 2023. 1,757 funds tracked by Wall St. Rank hold CVS as of Q1 2025.

  • Marex Group reported no remaining CVS Health position as of Q1 2025 after selling out during the quarter.
  • Marex Group sold 36,559 CVS Health shares in Q1 2025, an estimated $1.64M.
  • Marex Group first reported a position in CVS Health in Q2 2023 and held it in 7 quarters.
  • Marex Group's CVS Health position peaked at $7.14M in Q4 2023.
  • 1,757 funds tracked by Wall St. Rank held CVS Health as of Q1 2025.

Based on Marex Group's 13F filing for Q1 2025, filed 2 Apr 2026.